Comparison of Puff Volume with Cigarettes per Day in Predicting Nicotine Uptake among Daily Smokers

American Journal of Epidemiology

Volumn 184, Issue 1, 2016, Pages 48-57

  Krebs, Nicolle M ^a   Chen, Allshine ^a   Zhu, Junjia ^a   Sun, Dongxiao ^a   Liao, Jason ^a   Stennett, Andrea L ^a   Muscat, Joshua E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

tobacco dependence

Indexed keywords

3' HYDROXYCOTININE; BIOLOGICAL MARKER; COTININE; NICOTINE;

COMPARATIVE STUDY; EQUIPMENT; HEALTH RISK; METABOLITE; SMOKING; SPATIOTEMPORAL ANALYSIS; TOBACCO;

ADULT; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HIGH SCHOOL GRADUATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTABLE EQUIPMENT; SALIVA LEVEL; SMOKING; TOBACCO DEPENDENCE; TOPOGRAPHY; TOTAL DAILY PUFF VOLUME; VOLUME; ADDICTION; COMPARATIVE STUDY; METABOLISM; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SALIVA;

PENNSYLVANIA; UNITED STATES;

NEPTUNIA; NICOTIANA TABACUM;

ADULT; BEHAVIOR, ADDICTIVE; COTININE; HUMANS; NICOTINE; REGRESSION ANALYSIS; SALIVA; SMOKING;

EID: 84977111365     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv341     Document Type: Article

References (52)

1. Jacobs DR Jr, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: Twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med. 1999;159(7): 733-740.
2. Streppel MT, Boshuizen HC, Ocké MC, et al. Mortality and life expectancy in relation to long-Term cigarette, cigar and pipe smoking: The Zutphen Study. Tob Control. 2007;16(2): 107-113.
3. Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality-beyond established causes. N Engl J Med. 2015; 372(7):631-640.
4. Wagenknecht LE, Cutter GR, Haley NJ, et al. Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health. 1990;80(9):1053-1056.
5. Pickett KE, Rathouz PJ, Kasza K, et al. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol. 2005;19(5):368-376.
6. Fu M, Fernandez E, Martínez-Sánchez JM, et al. Salivary cotinine concentrations in daily smokers in Barcelona, Spain: A cross-sectional study. BMC Public Health. 2009;9:320.
7. Mustonen TK, Spencer SM, Hoskinson RA, et al. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res. 2005;7(4):581-590.
8. Richie JP Jr, Carmella SG, Muscat JE, et al. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev. 1997; 6(10):783-790.
9. Vineis P, Kogevinas M, Simonato L, et al. Levelling-off of the risk of lung and bladder cancer in heavy smokers: An analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res. 2000;463(1):103-110.
10. Hatsukami DK, Lemmonds C, Zhang Y, et al. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J Natl Cancer Inst. 2004;96(11):844-852.
11. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 2005;14(12): 2963-2968.
12. Hill P, Haley NJ, Wynder EL. Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis. 1983;36(6):439-449.
13. OConnor RJ, Giovino GA, Kozlowski LT, et al. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol. 2006;164(8):750-759.
14. Benowitz NL, Dains KM, Dempsey D, et al. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob Res. 2011; 13(9):772-783.
15. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998;280(2):135-139.
16. Olivieri M, Poli A, Zuccaro P, et al. Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health. 2002;57(4):355-359.
17. Blackford AL, Yang G, Hernandez-Avila M, et al. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1799-1804.
18. Vesey CJ, Saloojee Y, Cole PV, et al. Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed). 1982;284(6328):1516-1518.
19. Vogt TM, Selvin S, Hulley SB. Comparison of biochemical and questionnaire estimates of tobacco exposure. Prev Med. 1979; 8(1):23-33.
20. Scherer G. Smoking behaviour and compensation: A review of the literature. Psychopharmacology (Berl). 1999;145(1):1-20.
21. Tobin MJ, Jenouri G, Sackner MA. Subjective and objective measurement of cigarette smoke inhalation. Chest. 1982;82(6): 696-700.
22. Shahab L, Hammond D, OConnor RJ, et al. The reliability and validity of self-reported puffing behavior: evidence from a cross-national study. Nicotine Tob Res. 2008;10(5):867-874.
23. Lee EM, Malson JL, Waters AJ, et al. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res. 2003;5(5):673-679.
24. Hammond D, Fong GT, Cummings KM, et al. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 2005;14(6):1370-1375.
25. Blank MD, Disharoon S, Eissenberg T. Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res. 2009;11(7):896-903.
26. Williams JM, Gandhi KK, Lu SE, et al. Nicotine intake and smoking topography in smokers with bipolar disorder. Bipolar Disord. 2012;14(6):618-627.
27. Grainge MJ, Shahab L, Hammond D, et al. First cigarette on waking and time of day as predictors of puffing behaviour in UK adult smokers. Drug Alcohol Depend. 2009;101(3): 191-195.
28. Hamilton CM, Strader LC, Pratt JG, et al. The PhenX Toolkit: get the most fromyour measures. Am J Epidemiol. 2011;174(3): 253-260.
29. Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
30. Chen G, Giambrone NE Jr, Dluzen DF, et al. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Res. 2010;70(19):7543-7552.
31. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182.
32. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36(4):717-731.
33. Tingley D, Yamamoto T, Hirose K, et al. mediation: R package for causal mediation analysis. J Stat Softw. 2014;59(5): 1-38.
34. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9): 1119-1127.
35. Marian C, OConnor RJ, Djordjevic MV, et al. Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3305-3320.
36. Lubin JH, Caporaso NE. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 2006;15(3):517-523.
37. Lubin JH, Purdue M, Kelsey K, et al. Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: A pooled analysis of case-control studies. Am J Epidemiol. 2009;170(8):937-947.
38. Lubin JH, Alavanja MC, Caporaso N, et al. Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol. 2007;166(4):479-489.
39. Lubin JH, Virtamo J, Weinstein SJ, et al. Cigarette smoking and cancer: intensity patterns in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finnish men. Am J Epidemiol. 2008;167(8):970-975.
40. Benowitz NL, Pomerleau OF, Pomerleau CS, et al. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res. 2003;5(5):621-624.
41. Pérez-Stable EJ, Herrera B, Jacob P 3rd, et al. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152-156.
42. Curtin GM, Sulsky SI, Van Landingham C, et al. Patterns of menthol cigarette use among current smokers, overall and within demographic strata, based on data from four U.S. government surveys. Regul Toxicol Pharmacol. 2014;70(1): 189-196.
43. Giovino GA, Villanti AC, Mowery PD, et al. Differential trends in cigarette smoking in the USA: is menthol slowing progress? Tob Control. 2015;24(1):28-37.
44. Foulds J, Veldheer S, Hrabovsky S, et al. The effect of motivational lung age feedback on short-Term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study. Drug Alcohol Depend. 2015;153: 271-277.
45. Perkins KA, Jao NC, Karelitz JL. Consistency of daily cigarette smoking amount in dependent adults. Psychol Addict Behav. 2013;27(3):723-729.
46. van Vunakis H, Tashkin DP, Rigas B, et al. Relative sensitivity and specificity of salivary and serum cotinine in identifying tobacco-smoking status of self-reported nonsmokers and smokers of tobacco and/or marijuana. Arch Environ Health. 1989;44(1):53-58.
47. Zhu AZ, Renner CC, Hatsukami DK, et al. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: The influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev. 2013;22(4):708-718.
48. Macqueen DA, HeckmanBW, Blank MD, et al. Variation in the α 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content. Pharmacogenomics J. 2014;14(1):70-76.
49. Bobak M, Jarvis MJ, Skodova Z, et al. Smoke intake among smokers is higher in lower socioeconomic groups. Tob Control. 2000;9(3):310-312.
50. Pennanen M, Broms U, Korhonen T, et al. Smoking, nicotine dependence and nicotine intake by socio-economic status and marital status. Addict Behav. 2014;39(7): 1145-1151.
51. Laugesen M, Epton M, Frampton CM, et al. Hand-rolled cigarette smoking patterns compared with factory-made cigarette smoking in New Zealand men. BMC Public Health. 2009;9:194.
52. Brody AL, Mandelkern MA, London ED, et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006;63(8):907-915.